241 related articles for article (PubMed ID: 34209590)
21. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.
Lau WY; Kennedy AS; Kim YH; Lai HK; Lee RC; Leung TW; Liu CS; Salem R; Sangro B; Shuter B; Wang SC
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):401-7. PubMed ID: 20950954
[TBL] [Abstract][Full Text] [Related]
22. Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy.
Gulec SA; Sztejnberg ML; Siegel JA; Jevremovic T; Stabin M
J Nucl Med; 2010 Feb; 51(2):301-10. PubMed ID: 20080888
[TBL] [Abstract][Full Text] [Related]
23. Holmium-166 Microsphere Radioembolization of Hepatic Malignancies.
Reinders MTM; Smits MLJ; van Roekel C; Braat AJAT
Semin Nucl Med; 2019 May; 49(3):237-243. PubMed ID: 30954190
[TBL] [Abstract][Full Text] [Related]
24. [
Vimalnath KV; Rajeswari A; Dixit A; Chakravarty R; Sarma HD; Kulkarni S; Jha A; Puranik A; Rangarajan V; Goswami M; Chakraborty S
Cancer Biother Radiopharm; 2024 Feb; 39(1):82-91. PubMed ID: 38265675
[No Abstract] [Full Text] [Related]
25. A descriptive analysis of remnant activity during (90)Y resin microspheres radioembolization of hepatic tumors: technical factors and dosimetric implications.
Rodríguez LS; Thang SP; Li H; Khor LK; Tay YS; Myint KO; Tong AK
Ann Nucl Med; 2016 Apr; 30(3):255-61. PubMed ID: 26692012
[TBL] [Abstract][Full Text] [Related]
26. Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types.
Lam MG; Banerjee A; Goris ML; Iagaru AH; Mittra ES; Louie JD; Sze DY
Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1192-201. PubMed ID: 25916740
[TBL] [Abstract][Full Text] [Related]
27. Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.
Sarwar A; Kudla A; Weinstein JL; Ali A; Malik R; Bullock A; Khwaja KO; Curry M; Faintuch S; Ahmed M
Eur Radiol; 2021 Mar; 31(3):1316-1324. PubMed ID: 32901301
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors.
Bilbao JI; Garrastachu P; Herráiz MJ; Rodríguez M; Iñarrairaegui M; Rodríguez J; Hernández C; de la Cuesta AM; Arbizu J; Sangro B
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):523-31. PubMed ID: 19841973
[TBL] [Abstract][Full Text] [Related]
29. Occupational radiation exposure of medical staff performing ⁹⁰Y-loaded microsphere radioembolization.
Laffont S; Rolland Y; Ardisson V; Edeline J; Pracht M; Le Sourd S; Rohou T; Lenoir L; Lepareur N; Garin E
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):824-831. PubMed ID: 26686335
[TBL] [Abstract][Full Text] [Related]
30. Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.
Flamen P; Vanderlinden B; Delatte P; Ghanem G; Ameye L; Van Den Eynde M; Hendlisz A
Phys Med Biol; 2008 Nov; 53(22):6591-603. PubMed ID: 18978442
[TBL] [Abstract][Full Text] [Related]
31. Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.
Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Mali WP; van Het Schip AD; Zonnenberg BA
Lancet Oncol; 2012 Oct; 13(10):1025-34. PubMed ID: 22920685
[TBL] [Abstract][Full Text] [Related]
32.
Spyridonidis T; Papathanasiou N; Spyridonidis J; Ntzoumani C; Spyropoulou D; Katsanos K; Apostolopoulos DJ
Hell J Nucl Med; 2020; 23(3):330-338. PubMed ID: 33306761
[TBL] [Abstract][Full Text] [Related]
33. Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.
Al-Adra DP; Gill RS; Axford SJ; Shi X; Kneteman N; Liau SS
Eur J Surg Oncol; 2015 Jan; 41(1):120-7. PubMed ID: 25449754
[TBL] [Abstract][Full Text] [Related]
34. Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres.
Evans KA; Richardson MG; Pavlakis N; Morris DL; Liauw W; Bester L
J Vasc Interv Radiol; 2010 Oct; 21(10):1521-6. PubMed ID: 20813542
[TBL] [Abstract][Full Text] [Related]
35. Identifying aberrant hepatic arteries prior to intra-arterial radioembolization.
van den Hoven AF; Smits ML; de Keizer B; van Leeuwen MS; van den Bosch MA; Lam MG
Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1482-93. PubMed ID: 24469409
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of Radioembolization with
Prince JF; van den Bosch MAAJ; Nijsen JFW; Smits MLJ; van den Hoven AF; Nikolakopoulos S; Wessels FJ; Bruijnen RCG; Braat MNGJA; Zonnenberg BA; Lam MGEH
J Nucl Med; 2018 Apr; 59(4):582-588. PubMed ID: 28916623
[TBL] [Abstract][Full Text] [Related]
37. Yttrium 90 microspheres for the treatment of hepatocellular carcinoma.
Memon K; Lewandowski RJ; Riaz A; Salem R
Recent Results Cancer Res; 2013; 190():207-24. PubMed ID: 22941023
[TBL] [Abstract][Full Text] [Related]
38. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A
Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
[TBL] [Abstract][Full Text] [Related]
39. Serious hepatic complications of selective internal radiation therapy with yttrium-90 microsphere radioembolization for unresectable liver tumors.
Kuo JC; Tazbirkova A; Allen R; Kosmider S; Gibbs P; Yip D
Asia Pac J Clin Oncol; 2014 Sep; 10(3):266-72. PubMed ID: 25135200
[TBL] [Abstract][Full Text] [Related]
40. Computer modeling of yttrium-90-microsphere transport in the hepatic arterial tree to improve clinical outcomes.
Kennedy AS; Kleinstreuer C; Basciano CA; Dezarn WA
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):631-7. PubMed ID: 19910131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
